Henovcom to Present at the 5th mRNA-Based Therapeutics Summit in Boston, USA.
2025-07-20
Henovcom will participate in the 5th mRNA-Based Therapeutics Summit in Boston, USA. The COO, Junlan Ren, will deliver a presentation titled “Novel Efficient Cap Analog and Rapidly Eliminated Ionizable Lipid Improve the Efficacy and Safety of mRNA-Based Protein Replacement Therapy,” and will also participate in poster session.
